Igor V Maev Selected Research

lipostabil

1/2020	Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia.
1/2020	Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Igor V Maev Research Topics

Disease

6	Non-alcoholic Fatty Liver Disease 12/2022 - 01/2019
2	Liver Diseases (Liver Disease) 12/2022 - 01/2021
1	Inflammation (Inflammations) 12/2022
1	Fibrosis (Cirrhosis) 12/2022
1	Hepatitis 01/2021
1	Fatty Liver 01/2021
1	Infections 09/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Gastritis 01/2019
1	Hemorrhage 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Obesity 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Overweight 01/2019
1	Crohn Disease (Crohn's Disease) 01/2017

Drug/Important Bio-Agent (IBA)

3	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2020 - 01/2019
2	essential 303 forteIBA 09/2021 - 01/2021
2	lipostabilIBA 01/2020 - 01/2020
1	AntioxidantsIBA 12/2022
1	SilymarinIBA 12/2022
1	Ointments (Pastes)IBA 01/2021
1	EnzymesIBA 01/2020
1	rebamipideIBA 09/2019
1	AntralIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	CDECIBA 01/2017

Therapy/Procedure

5	Therapeutics 09/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 09/2021 - 01/2019